{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:20:31Z","timestamp":1785468031300,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,13]]},"DOI":"10.7759\/cureus.73607","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:30:47Z","timestamp":1731515447000},"source":"Crossref","is-referenced-by-count":1,"title":["Utility of Multiparametric Prostate MRI to Predict Regional or Distant Metastatic Disease Against Conventional Staging Using CT and Bone Scintigraphy or 68Ga-PSMA PET in Intermediate-to-High-Risk Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Minhtuan","family":"Nguyenhuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Qian","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Homewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Ogluszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Dundee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel RL","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016, 66:7-30. 10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0219","article-title":"Assessment of the diagnostic accuracy of biparametric magnetic resonance imaging for prostate cancer in biopsy-naive men: the Biparametric MRI for Detection of Prostate Cancer (BIDOC) study","volume":"1","author":"Boesen L","year":"2018","unstructured":"Boesen L, N\u00f8rgaard N, L\u00f8gager V, et al.. Assessment of the diagnostic accuracy of biparametric magnetic resonance imaging for prostate cancer in biopsy-naive men: the Biparametric MRI for Detection of Prostate Cancer (BIDOC) study. JAMA Netw Open. 2018, 1:e180219. 10.1001\/jamanetworkopen.2018.0219","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan V","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, et al.. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018, 378:1767-77. 10.1056\/NEJMoa1801993","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m T","year":"2021","unstructured":"Nordstr\u00f6m T, Discacciati A, Bergman M, et al.. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Lancet Oncol. 2021, 22:1240-9. 10.1016\/S1470-2045(21)00348-X","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.04.101","article-title":"AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer","volume":"198","author":"Fulgham PF","year":"2017","unstructured":"Fulgham PF, Rukstalis DB, Turkbey IB, et al.. AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol. 2017, 198:832-8. 10.1016\/j.juro.2017.04.101","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08945-7","article-title":"Validating the screening criteria for bone metastases in treatment-na\u00efve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases","volume":"32","author":"Rud E","year":"2022","unstructured":"Rud E, Noor D, Galtung KF, Ottosson F, Jacewicz M, Baco E, Lauritzen PM. Validating the screening criteria for bone metastases in treatment-na\u00efve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases. Eur Radiol. 2022, 32:8266-75. 10.1007\/s00330-022-08945-7","journal-title":"Eur Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07363-x","article-title":"The prevalence and locations of bone metastases using whole-body MRI in treatment-na\u00efve intermediate- and high-risk prostate cancer","volume":"31","author":"Ottosson F","year":"2021","unstructured":"Ottosson F, Baco E, Lauritzen PM, Rud E. The prevalence and locations of bone metastases using whole-body MRI in treatment-na\u00efve intermediate- and high-risk prostate cancer. Eur Radiol. 2021, 31:2747-53. 10.1007\/s00330-020-07363-x","journal-title":"Eur Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-014-1903-9","article-title":"Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis","volume":"43","author":"Shen G","year":"2014","unstructured":"Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol. 2014, 43:1503-13. 10.1007\/s00256-014-1903-9","journal-title":"Skeletal Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels AM","year":"2008","unstructured":"H\u00f6vels AM, Heesakkers RA, Adang EM, et al.. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008, 63:387-95. 10.1016\/j.crad.2007.05.022","journal-title":"Clin Radiol"},{"key":"ref10","unstructured":"Prostate Imaging Reporting & Data System (PI-RADS\u00ae). https.\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/PI-RADS."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2007.06.004","article-title":"MR imaging of the prostate: 1.5T versus 3T","volume":"15","author":"Cornfeld DM","year":"2007","unstructured":"Cornfeld DM, Weinreb JC. MR imaging of the prostate: 1.5T versus 3T. Magn Reson Imaging Clin N Am. 2007, 15:433-48, viii. 10.1016\/j.mric.2007.06.004","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.22020","article-title":"Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model","volume":"31","author":"Choi SH","year":"2010","unstructured":"Choi SH, Kim KH, Moon WK, Kim HC, Cha JH, Paik JH, Chang KH. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model. J Magn Reson Imaging. 2010, 31:134-41. 10.1002\/jmri.22020","journal-title":"J Magn Reson Imaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman MS","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, et al.. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020, 395:1208-16. 10.1016\/S0140-6736(20)30314-7","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.0586","article-title":"Gleason score 6 adenocarcinoma: should it be labeled as cancer?","volume":"30","author":"Carter HB","year":"2012","unstructured":"Carter HB, Partin AW, Walsh PC, et al.. Gleason score 6 adenocarcinoma: should it be labeled as cancer?. J Clin Oncol. 2012, 30:4294-6. 10.1200\/JCO.2012.44.0586","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90108-f","article-title":"Histologic grading of prostate cancer: a perspective","volume":"23","author":"Gleason DF","year":"1992","unstructured":"Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol. 1992, 23:273-9. 10.1016\/0046-8177(92)90108-f","journal-title":"Hum Pathol"},{"key":"ref16","article-title":"Measures of diagnostic accuracy: basic definitions","volume":"19","author":"\u0160imundi\u0107 AM","year":"2009","unstructured":"\u0160imundi\u0107 AM. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009, 19:203-11.","journal-title":"EJIFCC"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235803","article-title":"Pelvic lymphadenectomy may not improve biochemical recurrence-free survival in patients with prostate cancer treated with robot-assisted radical prostatectomy in Japan","volume":"14","author":"Namiki S","year":"2022","unstructured":"Namiki S, Kawase M, Ebara S, et al.. Pelvic lymphadenectomy may not improve biochemical recurrence-free survival in patients with prostate cancer treated with robot-assisted radical prostatectomy in Japan. Cancers (Basel). 2022, 14:5803. 10.3390\/cancers14235803","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54261-4","article-title":"Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion > 5%: a propensity score matching analysis from SEER database","volume":"9","author":"Chen J","year":"2019","unstructured":"Chen J, Wang Z, Zhao J, et al.. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion > 5%: a propensity score matching analysis from SEER database. Sci Rep. 2019, 9:17985. 10.1038\/s41598-019-54261-4","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.09.053","article-title":"Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE","volume":"177","author":"Berglund RK","year":"2007","unstructured":"Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol. 2007, 177:526-29; discussion 529-30. 10.1016\/j.juro.2006.09.053","journal-title":"J Urol"},{"key":"ref20","article-title":"Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?","volume":"12","author":"Loeb S","year":"2010","unstructured":"Loeb S, Partin AW, Schaeffer EM. Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?. Rev Urol. 2010, 12:20-4.","journal-title":"Rev Urol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.15.15761","article-title":"Identification of bone metastasis with routine prostate MRI: a study of patients with newly diagnosed prostate cancer","volume":"206","author":"Woo S","year":"2016","unstructured":"Woo S, Kim SY, Kim SH, Cho JY. Identification of bone metastasis with routine prostate MRI: a study of patients with newly diagnosed prostate cancer. AJR Am J Roentgenol. 2016, 206:1156-63. 10.2214\/AJR.15.15761","journal-title":"AJR Am J Roentgenol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46386-3","article-title":"Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to (68)Ga-PSMA PET-CT","volume":"9","author":"Mei\u00dfner S","year":"2019","unstructured":"Mei\u00dfner S, Janssen JC, Prasad V, Diederichs G, Hamm B, Brenner W, Makowski MR. Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to (68)Ga-PSMA PET-CT. Sci Rep. 2019, 9:10727. 10.1038\/s41598-019-46386-3","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2018.08.04","article-title":"Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer","volume":"7","author":"Caglic I","year":"2018","unstructured":"Caglic I, Barrett T. Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer. Transl Androl Urol. 2018, 7:814-23. 10.21037\/tau.2018.08.04","journal-title":"Transl Androl Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2023.100487","article-title":"Prediction of pelvic lymph node metastases and PSMA PET positive pelvic lymph nodes with multiparametric MRI and clinical information in primary staging of prostate cancer","volume":"10","author":"H\u00f6tker AM","year":"2023","unstructured":"H\u00f6tker AM, M\u00fchlematter U, Beintner-Skawran S, et al.. Prediction of pelvic lymph node metastases and PSMA PET positive pelvic lymph nodes with multiparametric MRI and clinical information in primary staging of prostate cancer. Eur J Radiol Open. 2023, 10:100487. 10.1016\/j.ejro.2023.100487","journal-title":"Eur J Radiol Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-016-0851-3","article-title":"Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis","volume":"42","author":"Vargas HA","year":"2017","unstructured":"Vargas HA, Schor-Bardach R, Long N, et al.. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. Abdom Radiol (NY). 2017, 42:271-7. 10.1007\/s00261-016-0851-3","journal-title":"Abdom Radiol (NY)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed HU","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, et al.. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017, 389:815-22. 10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317841-utility-of-multiparametric-prostate-mri-to-predict-regional-or-distant-metastatic-disease-against-conventional-staging-using-ct-and-bone-scintigraphy-or-68ga-psma-pet-in-intermediate-to-high-risk-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:30:50Z","timestamp":1731515450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317841-utility-of-multiparametric-prostate-mri-to-predict-regional-or-distant-metastatic-disease-against-conventional-staging-using-ct-and-bone-scintigraphy-or-68ga-psma-pet-in-intermediate-to-high-risk-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.73607","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}